tradingkey.logo

Ligand Subsidiary Pelthos Therapeutics To Combine With Channel Therapeutics

ReutersApr 17, 2025 10:06 AM

- Channel Therapeutics Corp CHRO.A:

  • LIGAND SUBSIDIARY PELTHOS THERAPEUTICS TO COMBINE WITH CHANNEL THERAPEUTICS

  • CHANNEL THERAPEUTICS CORP - PROPOSED TRANSACTION WILL RAISE $50 MILLION IN EQUITY CAPITAL

  • CHANNEL THERAPEUTICS CORP - LIGAND IS ENTITLED TO A 13% ROYALTY ON WORLDWIDE SALES OF ZELSUVMI

  • CHANNEL THERAPEUTICS CORP -COMBINED CO TO OPERATE UNDER NAME PELTHOS THERAPEUTICS INC., TRADE ON NYSE AMERICAN EXCHANGE UNDER TICKER PTHS

  • CHANNEL THERAPEUTICS CORP - UPON COMPLETION OF DEAL, PLESHA TO BECOME CEO OF COMBINED CO AND KNUETTEL TO BECOME CFO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI